Incorporating molecular tools into early-stage clinical trials.
Main Author: | Robert J Weil |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2211557 |
Similar Items
-
Two-stage adaptive designs in early phase clinical trials
by: Xu, Jiajing, et al.
Published: (2014) -
Incorporating Environmental Realism into the Toxicity of Nanoparticles to Early Life Stage Fish
by: Bone, Audrey Jayne
Published: (2015) -
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
by: Cristina Hernández, et al.
Published: (2020-04-01) -
Incorporating alternative design clinical trials in network meta-analyses
by: Thorlund K, et al.
Published: (2014-12-01) -
Bayesian Approaches for design and evaluation of the Phase II clinical trials incorporating safety and the multiregional clinical trials
by: Cheng, Yu-Chieh, et al.
Published: (2017)